PGI11 Economic Evaluation of the Use of Peg-Interferon Alfa 2A in the Treatment of Patients with Chronic Hepatitis C Public Mexican Perspective
Abstract
Authors
D. Lechuga M. Alva
D. Lechuga M. Alva
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now